Trial
NCT01128452
Safety and Efficacy of EVT 101 in Treatment-Resistant Depression
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Janssen Research & Development, LLC
Collaborators
Hoffmann-La Roche
Condition
Depression
Intervention
EVT 101
Why stopped
Evotec has indicated that this study was discontinued due to a clinical hold issued by the FDA
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-28